Physician profile
Ryan M Graf
NPI 1487017794
$11,768.44
in general payments reported to CMS, 2019-2025
11 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,586 · 2023: $1,911 · 2024: $1,666 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,181 · Travel and Lodging: $2,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,181.16 |
| Travel and Lodging | $2,000.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,354.08 | 2022-2023 | Arthrex |
| Stryker Corporation | $3,767.14 | 2022-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Great Lakes Orthopedics | $1,389.61 | 2022 | |
| Fortis Surgical, LLC | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $356.73 | 2022-2024 | Rigidloop, Monovisc, Orthovisc |
| Smith+Nephew, INC. | $298.75 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Intellio Link Werewolf, N/A |
| Bioventus LLC | $150.42 | 2023-2025 | Durolane, Durolane, Xcell |
| Enduromed, LLC | $119.49 | 2024 | |
| Medical Device Business Services, INC. | $59.42 | 2023 | Bristow Latarjet |
| Catalyst Orthoscience | $53.73 | 2024 | Catalyst Csr Shoulder System |
| Convatec INC. | $19.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Graf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.